Traffic

www.fasenra.com

Severe Eosinophilic Asthma Treatment | FASENRA® (benralizumab) Subcutaneous Injection

Global Rank: #508,326

FASENRA® (benralizumab) is an add-on maintenance treatment for patients 6 and older who are diagnosed with severe eosinophilic asthma.

Total Visits

75K

Avg. Visit Duration

0:29

Pages per Visit

1.39

Bounce Rate

66.31%

Registration Date

2016-08-01
Visit Trends
Recent website traffic trends over time
MonthTraffic
2025-0245.784
2025-0347.193
2025-0455.157
2025-0575.118
Traffic Sources
Main traffic sources for this website
SourceTraffic Share
search56.70%
direct31.29%
paid referrals6.54%
referrals3.90%
social1.49%
mail0.07%
Region Distribution
Geographic distribution of website visitors
RegionPercentage
United States89.54%
United Kingdom5.17%
Australia4.73%
India0.56%
Top Keywords
Main keywords driving traffic to this website